Stem Cell Authority, Ltd.
No trades
About Stem Cell Authority, Ltd.
Sector
Industry
CEO
Chong Yi Yang
Website
Headquarters
Jingan
Founded
2001
Identifiers
3
ISIN US85857C1080
Stem Cell Authority, Ltd. is a clinical-stage biopharmaceutical company committed to the research and development of immune system disease treatments using small molecules and stem cell technology. The company was founded on March 5, 2001 and is headquartered in Shanghai,China.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SCAL is 0.0150 USD — it has increased by 14.90 K% in the past 24 hours. Watch Stem Cell Authority, Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Stem Cell Authority, Ltd. stocks are traded under the ticker SCAL.
SCAL reached its all-time high on Apr 26, 2005 with the price of 1.0400 USD, and its all-time low was 0.000001 USD and was reached on Dec 12, 2014. View more price dynamics on SCAL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SCAL stock is 99.33% volatile and has beta coefficient of −40.68. Track Stem Cell Authority, Ltd. stock price on the chart and check out the list of the most volatile stocks — is Stem Cell Authority, Ltd. there?
Yes, you can track Stem Cell Authority, Ltd. financials in yearly and quarterly reports right on TradingView.
No, SCAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SCAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Stem Cell Authority, Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Stem Cell Authority, Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Stem Cell Authority, Ltd. stock shows the strong buy signal. See more of Stem Cell Authority, Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.